Indivior PLC (LON:INDV – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 1,173 ($15.82) and last traded at GBX 1,173 ($15.82), with a volume of 268421 shares changing hands. The stock had previously closed at GBX 1,142 ($15.40).
Indivior Price Performance
The stock has a market cap of £1.82 billion, a P/E ratio of -967.61, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The company’s fifty day simple moving average is GBX 970.64 and its 200-day simple moving average is GBX 870.49.
Insider Transactions at Indivior
In other news, insider Juliet Thompson bought 1,925 shares of the stock in a transaction dated Wednesday, June 11th. The shares were acquired at an average price of GBX 1,388 ($18.72) per share, with a total value of £26,719 ($36,033.72). 3.44% of the stock is owned by company insiders.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read More
- Five stocks we like better than Indivior
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- MP Materials Stock Booms on New Government Positioning
- How to Start Investing in Real Estate
- Insider Selling Hits Market Leaders—Should You Be Worried?
- Insider Buying Explained: What Investors Need to Know
- AES Gains 20% as Private Equity Eyes AI Hyperscale Energy Player
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
